Table 1: Levels of hematological parameters in B6C3F1 mice.
AZT dose (mg/kg/d)
RBC count (106/mm3)
Hb content (g/dL)
MCV (μm3)
MCH (pg)
0-week
11-week
0-week
11-week
0-week
11-week
0-week
11-week
Male
Female
Male
Female
Male
Female
Male
Female
Male
Female
Male
Female
Male
Female
Male
Female
0
9.9 ± 0.3
10.1 ± 0.5
11.0a ± 0.1
11.5 ± 0.3
16.5 ± 0.6
16.9 ± 0.7
16.9 ± 0.5
18.2 ± 0.7
46.6 ± 0.2
47.0 ± 0.3
47.0 ± 2.0
48.5 ± 1.2
16.4 ± 0.3
16.6 ± 0.2
15.4 ± 0.5
15.8a ± 0.3
400
8.7 ± 0.7
9.8 ± 0.5
7.6 ± 0.4
7.3a ± 0.3
14.2 ± 1.2
16.5 ± 0.9
14.4 ± 0.9
14.4 ± 0.8
47.2 ± 0.3
46.8 ± 0.3
57.8a ± 0.3
60.5a,b ± 0.5
16.5 ± 0.1
16.7 ± 0.2
19.0a ± 0.1
19.8a,b ± 0.2
500
8.6 ± 0.7
10.0 ± 0.7
7.7 ± 0.1
8.4b ± 0.1
14.1 ± 1.2
16.5 ± 1.2
14.8 ± 0.3
16.5b ± 0.2
47.8 ± 0.3
46.7 ± 0.2
58.5a ± 0.5
60.3a,b ± 0.3
16.4 ± 0.1
16.4 ± 0.2
19.2a ± 0.1
19.7a,b ± 0.1
600
8.6 ± 0.7
8.8 ± 0.3
7.9 ± 0.5
6.7a ± 1.1
14.1 ± 1.2
14.4 ± 0.4
15.6 ± 0.8
13.6 ± 2.1
46.6 ± 0.7
46.2 ± 0.6
60.3a ± 0.7
63.0a ± 1.0
16.2 ± 0.2
16.2 ± 0.1
19.7a ± 0.2
20.6a ± 0.4
aindicates a significant () difference in hematological parameter at 11-week compared to 0-week for each sex.
bindicates a significant () sex-based difference in hematological parameter in female mice compared to male counterparts at 11-week. Values are presented as the mean ± SEM (–6). Also, a significant () dose-related response was noted in the RBC count, Hb content, MCV, and MCH level in both sexes.